- JP-listed companies
- Pharmarise Holdings Corporation
- Income statement
Pharmarise Holdings CorporationJP:2796
Market cap
¥6.4B
P/E ratio
22.6x
| 2011/05 | 2012/05 | 2013/05 | 2014/05 | 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | |
| Revenue | 26,825 | 29,607 | 33,357 | 38,221 | 39,506 | 48,512 | 52,949 | 54,562 | 51,728 | 51,030 | 52,324 | 51,608 | 52,030 | 54,466 | 63,508 |
| Cost of revenue | - | - | - | 32,208 | 33,130 | 41,582 | 45,731 | 46,612 | 44,386 | 43,592 | 44,256 | 43,491 | 43,896 | 46,017 | 54,542 |
| Gross profit | - | - | - | 6,013 | 6,376 | 6,930 | 7,218 | 7,950 | 7,342 | 7,437 | 8,067 | 8,117 | 8,134 | 8,449 | 8,965 |
| Gross margin (%) | - | - | - | ||||||||||||
| Operating income | - | - | - | 1,573 | 1,143 | 813 | 442 | 1,179 | 640 | 1,034 | 1,246 | 1,520 | 1,438 | 916 | 293 |
| Operating expenses | - | - | - | 4,440 | 5,232 | 6,117 | 6,775 | 6,771 | 6,702 | 6,402 | 6,821 | 6,596 | 6,695 | 7,533 | 8,671 |
| Income before tax | 1,343 | 1,471 | 1,228 | 1,272 | 998 | 660 | 324 | 1,092 | 590 | 1,023 | 1,288 | 1,517 | 1,431 | 833 | 136 |
| Provision for income taxes | - | - | - | 779 | 715 | 655 | 251 | 622 | 410 | 238 | 782 | 864 | 702 | 485 | 390 |
| Net income | 563 | 686 | 958 | 369 | 228 | 382 | 7 | -28 | 23 | 580 | 426 | 458 | 347 | -342 | -367 |
| Earnings per share | 8,877.83 | 9,143.88 | 127.73 | 46.55 | 25.31 | 42.44 | 0.85 | -3.19 | 2.55 | 61.11 | 45.83 | 47.99 | 35.45 | -33.41 | -32.48 |
| Diluted EPS | - | - | - | 46.31 | 24.99 | 41.55 | 0.83 | 25.79 | 2.24 | 46.38 | 34.64 | 36.29 | 26.89 | 94.3 | 16.59 |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | ||||||
| Dividend per share | 2,600 | 1,000 | 1,400 | 14 | 16 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 20 | 14 |